IL113411A - Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition - Google Patents

Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition

Info

Publication number
IL113411A
IL113411A IL11341195A IL11341195A IL113411A IL 113411 A IL113411 A IL 113411A IL 11341195 A IL11341195 A IL 11341195A IL 11341195 A IL11341195 A IL 11341195A IL 113411 A IL113411 A IL 113411A
Authority
IL
Israel
Prior art keywords
composition
treatment
hyperglycaemias
moxonidine
prophylaxis
Prior art date
Application number
IL11341195A
Other languages
English (en)
Other versions
IL113411A0 (en
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IL113411A0 publication Critical patent/IL113411A0/xx
Publication of IL113411A publication Critical patent/IL113411A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
IL11341195A 1994-07-01 1995-04-18 Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition IL113411A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4423177A DE4423177A1 (de) 1994-07-01 1994-07-01 Antihyperglykämisch wirksame Arzneimittel

Publications (2)

Publication Number Publication Date
IL113411A0 IL113411A0 (en) 1995-07-31
IL113411A true IL113411A (en) 1999-07-14

Family

ID=6522064

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11341195A IL113411A (en) 1994-07-01 1995-04-18 Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition

Country Status (23)

Country Link
US (1) US5712283A (no)
EP (1) EP0689837B1 (no)
JP (1) JP3841846B2 (no)
KR (1) KR100366130B1 (no)
CN (1) CN1092961C (no)
AT (1) ATE210444T1 (no)
AU (1) AU691580B2 (no)
CA (1) CA2152998C (no)
CZ (1) CZ287563B6 (no)
DE (2) DE4423177A1 (no)
DK (1) DK0689837T3 (no)
DZ (1) DZ1894A1 (no)
ES (1) ES2167385T3 (no)
FI (1) FI117374B (no)
HU (1) HU226946B1 (no)
IL (1) IL113411A (no)
NO (1) NO307029B1 (no)
NZ (1) NZ270990A (no)
PT (1) PT689837E (no)
RU (1) RU2145857C1 (no)
SK (1) SK282227B6 (no)
UA (1) UA27954C2 (no)
ZA (1) ZA954691B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2212294A1 (en) * 1995-02-28 1996-09-06 Beiersdorf-Lilly Gmbh Use of moxonidine for the treatment of atherosclerosis
WO1997046241A1 (en) * 1996-06-06 1997-12-11 Eli Lilly And Company Formulation and method for treating congestive heart failure
NO980546L (no) * 1997-02-11 1998-08-12 Lilly Co Eli Farmas°ytiske midler
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
JP2001520195A (ja) * 1997-10-17 2001-10-30 イーライ・リリー・アンド・カンパニー 医薬の増強
US6897019B1 (en) 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
PL372695A1 (en) * 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
WO2005039639A2 (en) * 2003-10-10 2005-05-06 Solvay Pharmaceuticals Gmbh Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker
RU2542462C2 (ru) * 2013-06-28 2015-02-20 Андрей Владиславович Струтынский Способ коррекции кризового течения гипертонической болезни и абдоминального ожирения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849537C2 (de) * 1978-11-15 1983-03-17 Beiersdorf Ag, 2000 Hamburg Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
JPH0840906A (ja) 1996-02-13
JP3841846B2 (ja) 2006-11-08
ES2167385T3 (es) 2002-05-16
FI953256A (fi) 1996-01-02
DK0689837T3 (da) 2002-03-11
CZ139395A3 (en) 1996-01-17
CZ287563B6 (en) 2000-12-13
NO952624D0 (no) 1995-06-30
PT689837E (pt) 2002-04-29
DE4423177A1 (de) 1996-01-04
CN1122224A (zh) 1996-05-15
EP0689837A2 (de) 1996-01-03
ATE210444T1 (de) 2001-12-15
DE59509928D1 (de) 2002-01-24
SK282227B6 (sk) 2001-12-03
UA27954C2 (uk) 2000-10-16
EP0689837B1 (de) 2001-12-12
NO952624L (no) 1996-01-02
US5712283A (en) 1998-01-27
DZ1894A1 (fr) 2002-02-17
RU2145857C1 (ru) 2000-02-27
CA2152998A1 (en) 1996-01-02
IL113411A0 (en) 1995-07-31
FI117374B (fi) 2006-09-29
ZA954691B (en) 1996-01-29
NO307029B1 (no) 2000-01-31
CN1092961C (zh) 2002-10-23
KR100366130B1 (ko) 2003-03-26
SK74995A3 (en) 1996-05-08
CA2152998C (en) 2002-09-03
AU1775795A (en) 1996-01-18
AU691580B2 (en) 1998-05-21
HU226946B1 (en) 2010-03-29
FI953256A0 (fi) 1995-06-30
EP0689837A3 (de) 1996-06-05
HU9501900D0 (en) 1995-08-28
KR960003729A (ko) 1996-02-23
HUT72599A (en) 1996-05-28
NZ270990A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
GEP20043315B (en) Non-Peptide GnRH Agents, Methods For Their Preparation and Use Thereof
GR3004482T3 (no)
IL113411A (en) Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition
GB9510037D0 (en) Improvements in or relating to organic compounds
CA2148194A1 (en) Cyclopeptides of the formula i
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
HU9400868D0 (en) Sparfloxacine salts and solutions containing same and process for producing them
HUT61763A (en) Process for producing xanthine derivatives and pharmaceutical compositions comprising same as active ingredient, against disorders of cerebration
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
MY110092A (en) Butyric acid derivatives
HUT57720A (en) Process for producing indole derivatives and pharmaceutical compositions comprising such compounds
TW222622B (no)
ZA921091B (en) Substituted benzofuranylpiperidine as a nootropic agent
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
ATE116296T1 (de) Säureadditionssalze einer optisch aktiven alaninanilidverbindung und diese enthaltende, pharmazeutische zusammensetzungen.
PH30180A (en) Leustroducsin h its preparation and its therapeutic use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees